International Science Innovation Week 2026 will convene world leaders in science, medicine, and innovation to advance collaboration in pandemic preparedness, virology, and cancer research. An initiative by the Global Virus Network, USF Health, and Tampa General Hospital (TGH) Cancer Institute, this five-day event will serve as a strategic platform to share discoveries, foster cross-sector partnerships, and accelerate solutions to global health challenges.
International Science Innovation Week 2026 will convene world leaders in science, medicine, and innovation to advance collaboration in pandemic preparedness, virology, and cancer research.
An initiative by the Global Virus Network, USF Health, and Tampa General Hospital (TGH) Cancer Institute, this five-day event will serve as a strategic platform to share discoveries, foster cross-sector partnerships, and accelerate solutions to global health challenges.
TGH Cancer Institute International Meeting
"Microbes, Genes and Cancer"
March 2-3, 2026
Formerly known in the field as the "Robert Gallo" meeting, this meeting will focus on the critical links between microbes, genetics, and cancer, with discussions highlighting emerging research and therapeutic innovations.
Formerly known in the field as the "Robert Gallo" meeting, this meeting will focus on the critical links between microbes, genetics, and cancer, with discussions highlighting emerging research and therapeutic innovations.
Organizing Committee
Robert Gallo, MD
TGH Cancer Institute; GVN;
USF Health Institute for Translational Virology & Innovation
Eduardo Sotomayor, MD
TGH Cancer Institute
Jack Pledger, PhD
TGH Cancer Institute
GVN Annual International Scientific Meeting
"Pandemic Preparedness?"
March 4-6, 2026
Bringing together leading virologists, infectious disease experts, and public health officials, this meeting will spotlight urgent viral threats, breakthroughs in pathogen surveillance, and innovations in vaccines, therapeutics, and diagnostics.
Bringing together leading virologists, infectious disease experts, and public health officials, this meeting will spotlight urgent viral threats, breakthroughs in pathogen surveillance, and innovations in vaccines, therapeutics, and diagnostics.
Organizing Committee
Mathew Evins
GVN
Christian Bréchot, MD, PhD
GVN;
USF Microbiomes Institute
Sten Vermund, MD, PhD
GVN;
USF Health College of Public Health
TGH Cancer Institute Featuring
Robert Gallo, MD
GVN; TGH Cancer Institute; USF Health Institute for Translational Virology & Innovation; U.S.A.
Steven Rosenberg, MD, PhD
National Cancer Institute; U.S.A.
Drew Pardoll, MD, PhD
Johns Hopkins School of Medicine; U.S.A.
Carl June, MD, PhD
University of Pennsylvania; U.S.A.
Rafi Ahmed, PhD
Emory University; U.S.A.
Carlo Croce, MD
The Ohio State University; U.S.A.
Riccardo Dalla- Favera, MD, PhD
Columbia University; U.S.A.
Timothy Yeatman, MD, FACS
TGH Cancer Institute; U.S.A.
Timothy Cover, MD, PhD
Vanderbilt University, U.S.A.
Masao Matsuoka, MD, PhD
Kumamoto University; Japan
Savita Pahwa, MD
Miami Miller School of Medicine; U.S.A.
Eric Engels, MD, MPH
National Cancer Institute; U.S.A.
Matthew Anderson, MD, PhD
TGH Cancer Institute and USF Health Morsani College of Medicine; U.S.A.
Helen Heslop, MD, Dsc (Hon)
Baylor College of Medicine; U.S.A.
Special Guest
Erling Norrby, MD, PhD
Karolinska Institutet; Sweden
GVN Featuring
Robert Gallo, MD
GVN; TGH Cancer Institute; USF Health Institute for Translational Virology & Innovation; U.S.A.
Quarraisha Abdool Karim, PhD
GVN; CAPRISA; University of KwaZulu-Natal/ UNAIDS; South Africa
Scott C. Weaver, MS, PhD
GVN; The University of Texas Medical Branch; U.S.A.
Sharon Lewin, MD, PhD
GVN; University of Melbourne; Australia
Salim Abdool Karim, MB, ChB
GVN; CAPRISA; Columbia University Irving Medical Center; South Africa
Igor Koralnik, MD
Northwestern University; U.S.A.
Eduardo Gotuzzo, MD
GVN; Universidad Peruana Cayetano Heredia; Peru
Peter Palese, PhD
GVN; Mount Sinai; U.S.A.
Deborah Williamson, PhD
University of St. Andrews; UK
Tomas Cihlar, PhD
GVN; Gilead Sciences; U.S.A.
Mihai Netea, PhD
GVN; Radboud University Nijmegen; Netherlands
Lisa Ng, PhD
GVN; A*STAR; Singapore
Late-Breaking Session: Advancing Broad-Spectrum Therapies for Epidemic and Pandemic Respiratory Viruses





